{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-06T17:10:11.051912+00:00","company":{"ticker":"IDYA","cik":1676725,"company_name":"IDEAYA Biosciences, Inc."},"pagination":{"limit":100,"returned":6,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","facts":[{"fact_type":"earnings_release","fact_key":"b507fd5e8aca1639b9892d492d85c4a1882a062f","cik":1676725,"ticker":"IDYA","company_name":"IDEAYA Biosciences, Inc.","filed_at":"2026-05-05T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"the first quarter ended March 31, 2026","report_date":"2026-05-05","result_type":"reported_results","revenue_text":null},"claim":"IDEAYA Biosciences, Inc. reported financial results for the first quarter ended March 31, 2026.","evidence_excerpt":"On May 5, 2026, IDEAYA Biosciences, Inc. (the “Company”) announced its financial results for the first quarter ended March 31, 2026.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-26-204944","anchor_url":"https://secwatch.observer/filing/0001193125-26-204944#claim-b507fd5e8aca1639b9892d492d85c4a1882a062f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1676725/000119312526204944/0001193125-26-204944-index.htm"},{"fact_type":"executive_change","fact_key":"a6b3fbf6de","cik":1676725,"ticker":"IDYA","company_name":"IDEAYA Biosciences, Inc.","filed_at":"2025-04-02T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":null,"interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Susan L. Kelley, M.D. resigned as Director at IDEAYA Biosciences, Inc..","evidence_excerpt":"Dr. Kelley will resign from the Board at the end of her current term, which will conclude immediately after the Annual Meeting.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-25-071309","anchor_url":"https://secwatch.observer/filing/0001193125-25-071309#claim-a6b3fbf6de","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1676725/000119312525071309/0001193125-25-071309-index.htm"},{"fact_type":"executive_change","fact_key":"062b6c4112","cik":1676725,"ticker":"IDYA","company_name":"IDEAYA Biosciences, Inc.","filed_at":"2025-02-10T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":null,"interim":false,"role":"Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Joshua Bleharski was appointed as Chief Financial Officer at IDEAYA Biosciences, Inc..","evidence_excerpt":"On February 10, 2025, the Board of Directors (the “Board”) of IDEAYA Biosciences, Inc. (the “Company”) appointed Joshua Bleharski, Ph.D. as Chief Financial Officer of the Company, effective early May 2025","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-25-023076","anchor_url":"https://secwatch.observer/filing/0001193125-25-023076#claim-062b6c4112","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1676725/000119312525023076/0001193125-25-023076-index.htm"},{"fact_type":"executive_change","fact_key":"3495d18f3d","cik":1676725,"ticker":"IDYA","company_name":"IDEAYA Biosciences, Inc.","filed_at":"2024-06-27T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-07-11","interim":false,"role":"Chief Legal Officer and Secretary","role_category":"general_counsel","successor_name":null,"successor_named":false},"claim":"Jason Throne resigned as Chief Legal Officer and Secretary at IDEAYA Biosciences, Inc..","evidence_excerpt":"On June 21, 2024, Jason Throne informed IDEAYA Biosciences, Inc. (the “Company”) of his voluntary resignation from his positions as Chief Legal Officer and Secretary of the Company.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-24-169573","anchor_url":"https://secwatch.observer/filing/0001193125-24-169573#claim-3495d18f3d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1676725/000119312524169573/0001193125-24-169573-index.htm"},{"fact_type":"earnings_release","fact_key":"37d0d70fe83494db97de21ff1cd5b2b1bcbf7b3f","cik":1676725,"ticker":"IDYA","company_name":"IDEAYA Biosciences, Inc.","filed_at":"2024-05-07T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"first quarter ended March 31, 2024","report_date":"2024-05-07","result_type":"reported_results","revenue_text":null},"claim":"IDEAYA Biosciences, Inc. reported financial results for first quarter ended March 31, 2024.","evidence_excerpt":"On May 7, 2024, IDEAYA Biosciences, Inc. (the “Company”) announced its financial results for the first quarter ended March 31, 2024.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000950170-24-053900","anchor_url":"https://secwatch.observer/filing/0000950170-24-053900#claim-37d0d70fe83494db97de21ff1cd5b2b1bcbf7b3f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1676725/000095017024053900/0000950170-24-053900-index.htm"},{"fact_type":"earnings_release","fact_key":"b2162f2894150e2bbba3175233687624ec782179","cik":1676725,"ticker":"IDYA","company_name":"IDEAYA Biosciences, Inc.","filed_at":"2024-02-20T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"the fourth quarter and full year ended December 31, 2023","report_date":"2024-02-20","result_type":"reported_results","revenue_text":null},"claim":"IDEAYA Biosciences, Inc. reported financial results for the fourth quarter and full year ended December 31, 2023.","evidence_excerpt":"On February 20, 2024, IDEAYA Biosciences, Inc. (the “Company”) announced its financial results for the fourth quarter and full year ended December 31, 2023.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000950170-24-016758","anchor_url":"https://secwatch.observer/filing/0000950170-24-016758#claim-b2162f2894150e2bbba3175233687624ec782179","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1676725/000095017024016758/0000950170-24-016758-index.htm"}]}